{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T00:47:16Z","timestamp":1773449236855,"version":"3.50.1"},"reference-count":106,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurochemistry International"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.neuint.2016.10.007","type":"journal-article","created":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T08:01:29Z","timestamp":1477987289000},"page":"138-147","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Partial MHC class II constructs as novel immunomodulatory therapy for stroke"],"prefix":"10.1016","volume":"107","author":[{"given":"Gil","family":"Benedek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur A.","family":"Vandenbark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nabil J.","family":"Alkayed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Halina","family":"Offner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuint.2016.10.007_bib1","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1167\/iovs.11-8419","article-title":"Neuroprotective effects of recombinant T-cell receptor ligand in autoimmune optic neuritis in HLA-DR2 mice","volume":"53","author":"Adamus","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.neuint.2016.10.007_bib2","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1167\/iovs.05-1242","article-title":"Treatment of autoimmune anterior uveitis with recombinant TCR ligands","volume":"47","author":"Adamus","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.neuint.2016.10.007_bib3","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/s12975-011-0085-1","article-title":"Recombinant T cell receptor ligands improve outcome after experimental cerebral ischemia","volume":"2","author":"Akiyoshi","year":"2011","journal-title":"Transl. Stroke Res."},{"key":"10.1016\/j.neuint.2016.10.007_bib4","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1161\/01.STR.27.10.1739","article-title":"Dynamics of polymorphonuclear leukocyte accumulation in acute cerebral infarction and their correlation with brain tissue damage","volume":"27","author":"Akopov","year":"1996","journal-title":"Stroke"},{"key":"10.1016\/j.neuint.2016.10.007_bib5","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1001\/jama.283.9.1145","article-title":"Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study","volume":"283","author":"Albers","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.neuint.2016.10.007_bib6","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1161\/01.STR.29.1.159","article-title":"Gender-linked brain injury in experimental stroke","volume":"29","author":"Alkayed","year":"1998","journal-title":"Stroke"},{"key":"10.1016\/j.neuint.2016.10.007_bib7","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1007\/s12975-013-0315-9","article-title":"Characterization of a new model of thromboembolic stroke in C57 black\/6J mice","volume":"5","author":"Ansar","year":"2014","journal-title":"Transl. Stroke Res."},{"key":"10.1016\/j.neuint.2016.10.007_bib8","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1007\/s12975-013-0268-z","article-title":"Phenotypic changes in immune cell subsets reflect increased infarct volume in male vs. female mice","volume":"4","author":"Banerjee","year":"2013","journal-title":"Transl. Stroke Res."},{"key":"10.1016\/j.neuint.2016.10.007_bib9","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1161\/01.STR.0000078308.77727.EA","article-title":"Adoptive transfer of myelin basic protein-tolerized splenocytes to naive animals reduces infarct size: a role for lymphocytes in ischemic brain injury?","volume":"34","author":"Becker","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.neuint.2016.10.007_bib10","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/eji.201243162","article-title":"Partial MHC class II constructs inhibit MIF\/CD74 binding and downstream effects","volume":"43","author":"Benedek","year":"2013","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.neuint.2016.10.007_bib11","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11011-013-9440-0","article-title":"A\u00a0novel HLA-DRalpha1-MOG-35-55 construct treats experimental stroke","volume":"29","author":"Benedek","year":"2014","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.neuint.2016.10.007_bib12","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/365756a0","article-title":"MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia","volume":"365","author":"Bernhagen","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.neuint.2016.10.007_bib13","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/nm1567","article-title":"MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment","volume":"13","author":"Bernhagen","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuint.2016.10.007_bib14","doi-asserted-by":"crossref","first-page":"14144","DOI":"10.1021\/bi00251a025","article-title":"Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration inhibitory factor (MIF)","volume":"33","author":"Bernhagen","year":"1994","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuint.2016.10.007_bib15","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1007\/s11011-015-9714-9","article-title":"Role for microglia in sex differences after ischemic stroke: importance of M2","volume":"30","author":"Bodhankar","year":"2015","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.neuint.2016.10.007_bib16","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1161\/STROKEAHA.114.006864","article-title":"Delayed pituitary adenylate cyclase-activating polypeptide delivery after brain stroke improves functional recovery by inducing m2 microglia\/macrophage polarization","volume":"46","author":"Brifault","year":"2015","journal-title":"Stroke"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.neuint.2016.10.007_bib17","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1007\/s10875-012-9781-1","article-title":"MIF, MIF alleles, and prospects for therapeutic intervention in autoimmunity","volume":"33","author":"Bucala","year":"2013","journal-title":"J.\u00a0Clin. Immunol."},{"key":"10.1016\/j.neuint.2016.10.007_bib18","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1093\/protein\/12.9.771","article-title":"Design, engineering and production of functional single-chain T cell receptor ligands","volume":"12","author":"Burrows","year":"1999","journal-title":"Protein Eng."},{"key":"10.1016\/j.neuint.2016.10.007_bib19","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1212\/WNL.0000000000000208","article-title":"Sex differences in quality of life after ischemic stroke","volume":"82","author":"Bushnell","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.neuint.2016.10.007_bib20","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/377068a0","article-title":"MIF as a glucocorticoid-induced modulator of cytokine production","volume":"377","author":"Calandra","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.neuint.2016.10.007_bib21","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1084\/jem.179.6.1895","article-title":"The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor","volume":"179","author":"Calandra","year":"1994","journal-title":"J.\u00a0Exp. Med."},{"issue":"Suppl.\u00a02","key":"10.1016\/j.neuint.2016.10.007_bib22","doi-asserted-by":"crossref","first-page":"S385","DOI":"10.1086\/374752","article-title":"Macrophage migration inhibitory factor and host innate immune defenses against bacterial sepsis","volume":"187","author":"Calandra","year":"2003","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.neuint.2016.10.007_bib23","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1161\/hs0202.103399","article-title":"Flow cytometric analysis of inflammatory cells in ischemic rat brain","volume":"33","author":"Campanella","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.neuint.2016.10.007_bib24","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3389\/fneur.2014.00019","article-title":"Experimental models of brain ischemia: a review of techniques, magnetic resonance imaging, and investigational cell-based therapies","volume":"5","author":"Canazza","year":"2014","journal-title":"Front. Neurol."},{"key":"10.1016\/j.neuint.2016.10.007_bib25","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nrneurol.2012.98","article-title":"The immunology of acute stroke","volume":"8","author":"Chamorro","year":"2012","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neuint.2016.10.007_bib26","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jneumeth.2015.09.013","article-title":"A\u00a0novel mouse model of thromboembolic stroke","volume":"256","author":"Chen","year":"2015","journal-title":"J.\u00a0Neurosci. Methods"},{"key":"10.1016\/j.neuint.2016.10.007_bib27","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.steroids.2009.10.014","article-title":"Sex shapes experimental ischemic brain injury","volume":"75","author":"Cheng","year":"2010","journal-title":"Steroids"},{"key":"10.1016\/j.neuint.2016.10.007_bib28","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.4049\/jimmunol.1200485","article-title":"Macrophage migration inhibitory factor potentiates autoimmune-mediated neuroinflammation","volume":"191","author":"Cox","year":"2013","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.neuint.2016.10.007_bib29","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0092-8674(00)81025-9","article-title":"Invariant chain structure and MHC class II function","volume":"84","author":"Cresswell","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.neuint.2016.10.007_bib30","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3389\/fnins.2015.00172","article-title":"Immune aging, dysmetabolism, and inflammation in neurological diseases","volume":"9","author":"Deleidi","year":"2015","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuint.2016.10.007_bib31","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1161\/01.STR.0000068410.07397.D7","article-title":"Sex differences in the clinical presentation, resource use, and 3-month outcome of acute stroke in Europe: data from a multicenter multinational hospital-based registry","volume":"34","author":"Di Carlo","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.neuint.2016.10.007_bib32","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/S0140-6736(08)60694-7","article-title":"Stroke","volume":"371","author":"Donnan","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.neuint.2016.10.007_bib33","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s12975-015-0436-4","article-title":"Partial MHC constructs treat thromboembolic ischemic stroke characterized by early immune expansion","volume":"7","author":"Dotson","year":"2016","journal-title":"Transl. Stroke Res."},{"key":"10.1016\/j.neuint.2016.10.007_bib34","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jneuroim.2014.11.020","article-title":"Splenectomy reduces infarct volume and neuroinflammation in male but not female mice in experimental stroke","volume":"278","author":"Dotson","year":"2015","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.neuint.2016.10.007_bib35","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3389\/fncel.2014.00284","article-title":"Different immunological mechanisms govern protection from experimental stroke in young and older mice with recombinant TCR ligand therapy","volume":"8","author":"Dotson","year":"2014","journal-title":"Front. Cell Neurosci."},{"key":"10.1016\/j.neuint.2016.10.007_bib36","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s11011-011-9241-2","article-title":"Therapy with recombinant T-cell receptor ligand reduces infarct size and infiltrating inflammatory cells in brain after middle cerebral artery occlusion in mice","volume":"26","author":"Dziennis","year":"2011","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.neuint.2016.10.007_bib37","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jstrokecerebrovasdis.2004.07.004","article-title":"Leukocyte count predicts outcome after ischemic stroke: the Northern Manhattan Stroke Study","volume":"13","author":"Elkind","year":"2004","journal-title":"J.\u00a0Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.neuint.2016.10.007_bib38","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1161\/STROKEAHA.108.534503","article-title":"Temporal and spatial dynamics of cerebral immune cell accumulation in stroke","volume":"40","author":"Gelderblom","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.neuint.2016.10.007_bib39","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nri978","article-title":"Alternative activation of macrophages","volume":"3","author":"Gordon","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.neuint.2016.10.007_bib40","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1074\/jbc.M703265200","article-title":"Macrophage migration inhibitory factor induces B cell survival by activation of a CD74-CD44 receptor complex","volume":"283","author":"Gore","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuint.2016.10.007_bib41","doi-asserted-by":"crossref","first-page":"4073","DOI":"10.4049\/jimmunol.1500046","article-title":"Naive T cell maintenance and function in human aging","volume":"194","author":"Goronzy","year":"2015","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.neuint.2016.10.007_bib42","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1002\/art.38090","article-title":"Macrophage migration inhibitory factor receptor CD74 mediates alphavirus-induced arthritis and myositis in murine models of alphavirus infection","volume":"65","author":"Herrero","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.neuint.2016.10.007_bib43","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1038\/jcbfm.2010.66","article-title":"Different strokes for different folks: the rich diversity of animal models of focal cerebral ischemia","volume":"30","author":"Howells","year":"2010","journal-title":"J.\u00a0Cereb. Blood Flow. Metab."},{"key":"10.1016\/j.neuint.2016.10.007_bib44","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1161\/STROKEAHA.112.659656","article-title":"Microglia\/macrophage polarization dynamics reveal novel mechanism of injury expansion after focal cerebral ischemia","volume":"43","author":"Hu","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.neuint.2016.10.007_bib45","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.4049\/jimmunol.180.2.1249","article-title":"MHC class II derived recombinant T cell receptor ligands protect DBA\/1LacJ mice from collagen-induced arthritis","volume":"180","author":"Huan","year":"2008","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.neuint.2016.10.007_bib46","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1038\/sj.jcbfm.9600482","article-title":"T- and B-cell-deficient mice with experimental stroke have reduced lesion size and inflammation","volume":"27","author":"Hurn","year":"2007","journal-title":"J.\u00a0Cereb. Blood Flow. Metab."},{"key":"10.1016\/j.neuint.2016.10.007_bib47","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1742-2094-8-75","article-title":"Lack of macrophage migration inhibitory factor in mice does not affect hallmarks of the inflammatory\/immune response during the first week after stroke","volume":"8","author":"Inacio","year":"2011","journal-title":"J.\u00a0Neuroinflamm."},{"key":"10.1016\/j.neuint.2016.10.007_bib48","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/jcbfm.2010.194","article-title":"Macrophage migration inhibitory factor promotes cell death and aggravates neurologic deficits after experimental stroke","volume":"31","author":"Inacio","year":"2011","journal-title":"J.\u00a0Cereb. Blood Flow. Metab."},{"key":"10.1016\/j.neuint.2016.10.007_bib49","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.nbd.2010.09.015","article-title":"Enriched environment downregulates macrophage migration inhibitory factor and increases parvalbumin in the brain following experimental stroke","volume":"41","author":"Inacio","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuint.2016.10.007_bib50","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1742-2094-7-75","article-title":"Characterization of human platelet binding of recombinant T cell receptor ligand","volume":"7","author":"Itakura","year":"2010","journal-title":"J.\u00a0Neuroinflamm."},{"key":"10.1016\/j.neuint.2016.10.007_bib51","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/jcbfm.1995.5","article-title":"Lymphocytic infiltration and expression of intercellular adhesion molecule-1 in photochemically induced ischemia of the rat cortex","volume":"15","author":"Jander","year":"1995","journal-title":"J.\u00a0Cereb. Blood Flow. Metab."},{"key":"10.1016\/j.neuint.2016.10.007_bib52","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1212\/NXI.0000000000000139","article-title":"Macrophage migration inhibitory factor promotes resistance to glucocorticoid treatment in EAE","volume":"2","author":"Ji","year":"2015","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.neuint.2016.10.007_bib53","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1189\/jlb.1109766","article-title":"Inflammatory mechanisms in ischemic stroke: role of inflammatory cells","volume":"87","author":"Jin","year":"2010","journal-title":"J.\u00a0Leukoc. Biol."},{"key":"10.1016\/j.neuint.2016.10.007_bib54","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jns.2016.06.039","article-title":"Stroke induces specific alteration of T memory compartment controlling auto-reactive CNS antigen-specific T cell responses","volume":"368","author":"Klehmet","year":"2016","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.neuint.2016.10.007_bib55","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/j.neurobiolaging.2012.12.014","article-title":"Aging enhances classical activation but mitigates alternative activation in the central nervous system","volume":"34","author":"Lee","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuint.2016.10.007_bib56","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/S0140-6736(10)60491-6","article-title":"Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials","volume":"375","author":"Lees","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.neuint.2016.10.007_bib57","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1084\/jem.20030286","article-title":"MIF signal transduction initiated by binding to CD74","volume":"197","author":"Leng","year":"2003","journal-title":"J.\u00a0Exp. Med."},{"issue":"10","key":"10.1016\/j.neuint.2016.10.007_bib58","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1096\/fj.201600495R","article-title":"mTORC1 pathway disruption ameliorates brain inflammation following stroke via a shift in microglia phenotype from M1 type to M2 type","volume":"30","author":"Li","year":"2016","journal-title":"FASEB J."},{"issue":"Suppl.\u00a0A100","key":"10.1016\/j.neuint.2016.10.007_bib59","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/ijs.12371","article-title":"World Stroke Organization global stroke services guidelines and action plan","volume":"9","author":"Lindsay","year":"2014","journal-title":"Int. J. Stroke"},{"key":"10.1016\/j.neuint.2016.10.007_bib60","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1161\/STROKEAHA.115.012079","article-title":"Interleukin-4 is essential for microglia\/macrophage M2 polarization and long-term recovery after cerebral ischemia","volume":"47","author":"Liu","year":"2016","journal-title":"Stroke"},{"key":"10.1016\/j.neuint.2016.10.007_bib61","doi-asserted-by":"crossref","first-page":"e56306","DOI":"10.1371\/journal.pone.0056306","article-title":"Partial MHC\/neuroantigen peptide constructs: a potential neuroimmune-based treatment for methamphetamine addiction","volume":"8","author":"Loftis","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neuint.2016.10.007_bib62","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.expneurol.2013.08.011","article-title":"Differential effects of aging and sex on stroke induced inflammation across the lifespan","volume":"249","author":"Manwani","year":"2013","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuint.2016.10.007_bib63","doi-asserted-by":"crossref","first-page":"4164","DOI":"10.4049\/jimmunol.1303118","article-title":"HLA-DRalpha1 constructs block CD74 expression and MIF effects in experimental autoimmune encephalomyelitis","volume":"192","author":"Meza-Romero","year":"2014","journal-title":"J.\u00a0Immunol."},{"issue":"4","key":"10.1016\/j.neuint.2016.10.007_bib64","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s13311-016-0469-8","article-title":"Antigen presentation after stroke","volume":"13","author":"Miro-Mur","year":"2016","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neuint.2016.10.007_bib65","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/jnc.12705","article-title":"Macrophages and CNS remyelination","volume":"130","author":"Miron","year":"2014","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuint.2016.10.007_bib66","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1073\/pnas.012511599","article-title":"Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response","volume":"99","author":"Mitchell","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuint.2016.10.007_bib67","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/ilar.45.2.147","article-title":"Stroke in the female: role of biological sex and estrogen","volume":"45","author":"Murphy","year":"2004","journal-title":"ILAR J."},{"key":"10.1016\/j.neuint.2016.10.007_bib68","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0092-8674(93)90417-O","article-title":"The chondroitin sulfate form of invariant chain can enhance stimulation of T cell responses through interaction with CD44","volume":"74","author":"Naujokas","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.neuint.2016.10.007_bib69","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/ana.20741","article-title":"1,026 experimental treatments in acute stroke","volume":"59","author":"O'Collins","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuint.2016.10.007_bib70","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/med.21385","article-title":"Targeting MIF in Cancer: therapeutic strategies, current developments, and future opportunities","volume":"36","author":"O'Reilly","year":"2016","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.neuint.2016.10.007_bib71","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jneuroim.2010.09.013","article-title":"RTL therapy for multiple sclerosis: a Phase I clinical study","volume":"231","author":"Offner","year":"2011","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.neuint.2016.10.007_bib72","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/sj.jcbfm.9600217","article-title":"Experimental stroke induces massive, rapid activation of the peripheral immune system","volume":"26","author":"Offner","year":"2006","journal-title":"J.\u00a0Cereb. Blood Flow. Metab."},{"key":"10.1016\/j.neuint.2016.10.007_bib73","doi-asserted-by":"crossref","first-page":"6523","DOI":"10.4049\/jimmunol.176.11.6523","article-title":"Splenic atrophy in experimental stroke is accompanied by increased regulatory T cells and circulating macrophages","volume":"176","author":"Offner","year":"2006","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.neuint.2016.10.007_bib74","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.neuroscience.2008.05.033","article-title":"Effect of experimental stroke on peripheral immunity: CNS ischemia induces profound immunosuppression","volume":"158","author":"Offner","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuint.2016.10.007_bib75","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1161\/STROKEAHA.107.487520","article-title":"Mouse model of in situ thromboembolic stroke and reperfusion","volume":"38","author":"Orset","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.neuint.2016.10.007_bib76","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1161\/STR.0b013e31829734f2","article-title":"Forecasting the future of stroke in the United States: a policy statement from the american heart association and american stroke association","volume":"44","author":"Ovbiagele","year":"2013","journal-title":"Stroke"},{"key":"10.1016\/j.neuint.2016.10.007_bib77","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s12975-014-0345-y","article-title":"Novel humanized recombinant T cell receptor ligands protect the female brain after experimental stroke","volume":"5","author":"Pan","year":"2014","journal-title":"Transl. Stroke Res."},{"key":"10.1016\/j.neuint.2016.10.007_bib78","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/jcbfm.2014.212","article-title":"The role of the spleen in ischemic stroke","volume":"35","author":"Pennypacker","year":"2015","journal-title":"J.\u00a0Cereb. Blood Flow. Metab."},{"key":"10.1016\/j.neuint.2016.10.007_bib79","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s11886-009-0080-2","article-title":"Stroke in women: disparities and outcomes","volume":"12","author":"Persky","year":"2010","journal-title":"Curr. Cardiol. Rep."},{"key":"10.1016\/j.neuint.2016.10.007_bib80","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1161\/CIRCRESAHA.116.308022","article-title":"Inflammatory disequilibrium in stroke","volume":"119","author":"Petrovic-Djergovic","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.neuint.2016.10.007_bib81","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.4049\/jimmunol.1102289","article-title":"Brain-derived antigens in lymphoid tissue of patients with acute stroke","volume":"188","author":"Planas","year":"2012","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.neuint.2016.10.007_bib82","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S1474-4422(08)70193-5","article-title":"Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomes","volume":"7","author":"Reeves","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuint.2016.10.007_bib83","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11011-011-9267-5","article-title":"Myelin specific cells infiltrate MCAO lesions and exacerbate stroke severity","volume":"27","author":"Ren","year":"2012","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.neuint.2016.10.007_bib84","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1016\/j.febslet.2009.07.058","article-title":"A\u00a0functional heteromeric MIF receptor formed by CD74 and CXCR4","volume":"583","author":"Schwartz","year":"2009","journal-title":"FEBS Lett."},{"key":"10.1016\/j.neuint.2016.10.007_bib85","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s11481-012-9406-8","article-title":"A\u00a0transient decrease in spleen size following stroke corresponds to splenocyte release into systemic circulation","volume":"7","author":"Seifert","year":"2012","journal-title":"J.\u00a0Neuroimmune Pharmacol."},{"key":"10.1016\/j.neuint.2016.10.007_bib86","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s11011-012-9283-0","article-title":"The spleen contributes to stroke induced neurodegeneration through interferon gamma signaling","volume":"27","author":"Seifert","year":"2012","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.neuint.2016.10.007_bib87","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.immuni.2006.08.020","article-title":"CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex","volume":"25","author":"Shi","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.neuint.2016.10.007_bib88","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jneuroim.2010.04.013","article-title":"Binding of recombinant T cell receptor ligands (RTL) to antigen presenting cells prevents upregulation of CD11b and inhibits T cell activation and transfer of experimental autoimmune encephalomyelitis","volume":"225","author":"Sinha","year":"2010","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.neuint.2016.10.007_bib89","doi-asserted-by":"crossref","first-page":"12531","DOI":"10.1523\/JNEUROSCI.3599-07.2007","article-title":"A\u00a0promising therapeutic approach for multiple sclerosis: recombinant T-cell receptor ligands modulate experimental autoimmune encephalomyelitis by reducing interleukin-17 production and inhibiting migration of encephalitogenic cells into the CNS","volume":"27","author":"Sinha","year":"2007","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuint.2016.10.007_bib90","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1161\/STROKEAHA.108.543991","article-title":"Recombinant T cell receptor ligand treats experimental stroke","volume":"40","author":"Subramanian","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.neuint.2016.10.007_bib91","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.cllc.2013.08.006","article-title":"Novel association between CD74 polymorphisms and hematologic toxicity in patients with NSCLC after platinum-based chemotherapy","volume":"15","author":"Tan","year":"2014","journal-title":"Clin. Lung Cancer"},{"key":"10.1016\/j.neuint.2016.10.007_bib92","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.nbd.2013.01.016","article-title":"Deletion of macrophage migration inhibitory factor worsens stroke outcome in female mice","volume":"54","author":"Turtzo","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuint.2016.10.007_bib93","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2217\/fnl.09.66","article-title":"Sex-specific responses to stroke","volume":"5","author":"Turtzo","year":"2010","journal-title":"Future Neurol."},{"key":"10.1016\/j.neuint.2016.10.007_bib94","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1161\/STROKEAHA.108.532085","article-title":"Monocytes are major players in the prognosis and risk of infection after acute stroke","volume":"40","author":"Urra","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.neuint.2016.10.007_bib95","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3389\/fncel.2014.00278","article-title":"Antigen-specific immune reactions to ischemic stroke","volume":"8","author":"Urra","year":"2014","journal-title":"Front. Cell Neurosci."},{"key":"10.1016\/j.neuint.2016.10.007_bib96","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jaut.2012.08.004","article-title":"A\u00a0novel regulatory pathway for autoimmune disease: binding of partial MHC class II constructs to monocytes reduces CD74 expression and induces both specific and bystander T-cell tolerance","volume":"40","author":"Vandenbark","year":"2013","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.neuint.2016.10.007_bib97","doi-asserted-by":"crossref","first-page":"127","DOI":"10.4049\/jimmunol.171.1.127","article-title":"Recombinant TCR ligand induces tolerance to myelin oligodendrocyte glycoprotein 35-55 peptide and reverses clinical and histological signs of chronic experimental autoimmune encephalomyelitis in HLA-DR2 transgenic mice","volume":"171","author":"Vandenbark","year":"2003","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.neuint.2016.10.007_bib98","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1111\/j.1471-4159.2006.04081.x","article-title":"Antigen-specific therapy promotes repair of myelin and axonal damage in established EAE","volume":"98","author":"Wang","year":"2006","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuint.2016.10.007_bib99","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s00592-014-0616-9","article-title":"CD74 indicates microglial activation in experimental diabetic retinopathy and exogenous methylglyoxal mimics the response in normoglycemic retina","volume":"51","author":"Wang","year":"2014","journal-title":"Acta Diabetol."},{"key":"10.1016\/j.neuint.2016.10.007_bib100","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1161\/STROKEAHA.108.530535","article-title":"Upregulation of macrophage migration inhibitory factor gene expression in stroke","volume":"40","author":"Wang","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.neuint.2016.10.007_bib101","doi-asserted-by":"crossref","first-page":"5787","DOI":"10.1016\/S0021-9258(19)39432-3","article-title":"Human major histocompatibility complex class II invariant chain is expressed on the cell surface","volume":"265","author":"Wraight","year":"1990","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuint.2016.10.007_bib102","first-page":"954739","article-title":"Recombinant t-cell receptor ligand (RTL) for treatment of multiple sclerosis: a double-blind, placebo-controlled, phase 1, dose-escalation study","volume":"2012","author":"Yadav","year":"2012","journal-title":"Autoimm. Dis."},{"key":"10.1016\/j.neuint.2016.10.007_bib103","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1750-3639.2012.00614.x","article-title":"Postischemic brain infiltration of leukocyte subpopulations differs among murine permanent and transient focal cerebral ischemia models","volume":"23","author":"Zhou","year":"2013","journal-title":"Brain Pathol."},{"key":"10.1016\/j.neuint.2016.10.007_bib104","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s12975-014-0373-7","article-title":"Preclinical evaluation of recombinant T cell receptor ligand RTL1000 as a therapeutic agent in ischemic stroke","volume":"6","author":"Zhu","year":"2015","journal-title":"Transl. Stroke Res."},{"key":"10.1016\/j.neuint.2016.10.007_bib105","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.neuroscience.2014.12.037","article-title":"Recombinant T-cell receptor ligand RTL1000 limits inflammation and decreases infarct size after experimental ischemic stroke in middle-aged mice","volume":"288","author":"Zhu","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuint.2016.10.007_bib106","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1007\/s12975-014-0348-8","article-title":"Recombinant T cell receptor ligand treatment improves neurological outcome in the presence of tissue plasminogen activator in experimental ischemic stroke","volume":"5","author":"Zhu","year":"2014","journal-title":"Transl. Stroke Res."}],"container-title":["Neurochemistry International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018616302753?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018616302753?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T08:32:18Z","timestamp":1718872338000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197018616302753"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":106,"alternative-id":["S0197018616302753"],"URL":"https:\/\/doi.org\/10.1016\/j.neuint.2016.10.007","relation":{},"ISSN":["0197-0186"],"issn-type":[{"value":"0197-0186","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Partial MHC class II constructs as novel immunomodulatory therapy for stroke","name":"articletitle","label":"Article Title"},{"value":"Neurochemistry International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuint.2016.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}